Glomerular function, impaired

Plasma volume and the extracellular fluid space have been observed to constrict 30% during reducing diets (300-600 calories per day) (B22). These changes can be accompanied by functional impairment of glomerular filtration and hepatic perfusion with transient increases up to 2 mg/100 ml in serum creatinine and BSP retention up to 40% (B22). In rare instances a significant fall in serum calcium, magnesium, or potassium was observed. Hyperuricemia was also observed, with concentrations as high as 9 mg/100 ml (B22). 

Renal function impairment No changes were observed in the pharmacokinetics of dipyridamole or its glucuronide metabolite with creatinine clearances ranging from approximately 15 mL/min to more than 100 mL/min if data were corrected for differences in age. Avoid aspirin in patients with severe renal failure (glomerular filtration rate less than 10 mL/min). 

Renal function Impairment Edema may occur in the presence of renal disease with a fixed or decreased glomerular filtration rate. 

Renal function impairment In hypertensive patients with normal kidneys who are treated with hydralazine, there is evidence of increased renal blood flow and a maintenance of glomerular filtration rate. Renal function may improve where control values were below normal prior to administration. Use with caution in patients with advanced renal damage. 

Renal function impairment Morphologic changes with glomerular and interstitial fibrosis and nephron atrophy have occurred in patients on chronic lithium therapy. The relationship between such changes and renal function has not been established. 

Renal function Impairment- Ceftazidime is excreted by the kidneys, almost exclusively by glomerular filtration. In patients with impaired renal function (glomerular filtration rate (GFR) less than 50 mL/min), reduce dosage to compensate for slower excretion. In patients with suspected renal insufficiency, give an initial loading dose of 1 g. Estimate GFR to determine the appropriate maintenance dose. 

Concurrent immunosuppressants Sirolimus has been administered concurrently with cyclosporine and corticosteroids. The efficacy and safety of the use of sirolimus in combination with other immunosuppressive agents have not been determined. Renai function impairment Mean serum creatinine was increased and mean glomerular filtration rate was decreased in patients treated with sirolimus and cyclosporine compared with those treated with cyclosporine and placebo or azathioprine controls. Monitor renal function during the administration of maintenance immunosuppression regimens including sirolimus in combination with cyclosporine, and consider appropriate adjustment of the immunosuppression... 

There is no final consensus on whether normal use of lithium, without any episode of toxicity (the vast majority of patients), may result in permanent renal impairment. Polyuria occurs in 20-40% and is due to inhibition of antidiuretic hormone (ADH) by lithium. It usually resolves on cessation of lithium as do any effects on glomerular function. Interference with thyroid function is due to inhibition of the action of thyroid stimulating hormone (TSH) and is easily managed by administration of thyroxine. Lithium is contraindicated during pregnancy (major vessel anomalies in fetus) and breastfeeding. 

The agreed mechanism of renal function impairment with ACE inhibitors is as follows when perfusion pressure or afferent arteriolar pressure is reduced in the glomerulus, glomerular filtration is maintained by efferent... 

Impaired glomerular function reduces the clearance of those water-soluble porphyrins normally excreted in the urine. Furthermore, these porphyrins are poorly cleared by dialysis and, as a consequence, plasma porphyrins are raised in end-stage renal failure. ... 

RENAL EXCRETION Excretion of drugs and metabolites in the urine involves three distinct processes glomerular filtration, active tubular secretion, and passive tubular reabsorption. Changes in overall renal function generally affect aU three processes to a similar extent. In neonates, renal function is low compared with body mass but matures rapidly within the first few months after birth. During adulthood, there is a slow decline in renal function, 1% per year, so that in elderly patients a substantial degree of functional impairment may be present. 

Alternatively (or as an associated mechanism), an urate overproduction at the kidney site in the course of CGN (possibly due to the glomerular cell hyperplasia) may be postulated. This hypothesis is consistent with the observation of increased sUr values in CGN patients with normal renal function, and with the sharp sUr increase in the early stages of renal function impairment in the patients of this group. 

Tenofovir can also cause impaired glomerular function [123 j. In 99 patients... 

Albalater M, Blanco F, Moreno V, Vispo E, Soriano V. Kidney tubular abnormalities in the absence of impaired glomerular function in HTV patients treated with tenofovir. AIDS 2009 23(6) 689 96. 

In the kidney, ANG II reduces renal blood flow and constricts preferentially the efferent arteriole of the glomerulus with the result of increased glomerular filtration pressure. ANG II further enhances renal sodium and water reabsorption at the proximal tubulus. ACE inhibitors thus increase renal blood flow and decrease sodium and water retention. Furthermore, ACE inhibitors are nephroprotective, delaying the progression of glomerulosclerosis. This also appears to be a result of reduced ANG II levels and is at least partially independent from pressure reduction. On the other hand, ACE inhibitors decrease glomerular filtration pressure due to the lack of ANG II-mediated constriction of the efferent arterioles. Thus, one important undesired effect of ACE inhibitors is impaired glomerular filtration rate and impaired kidney function. 

Furosemide and ethacrynic acid preserve glomerular filtration rate and are, therefore, the diuretic agents of choice in hypertensive patients with impairment of kidney function(17,18,... 

Toxicity Aminoglycosides are associated with significant nephrotoxicity or ototoxicity. These agents are excreted primarily by glomerular filtration thus, the serum half-life will be prolonged and significant accumulation will occur in patients with impaired renal function. Toxicity may develop even with conventional doses, particularly in prerenal azotemia or impaired renal function. 

Elevated BUN and serum creatinine It is not unusual for serum creatinine and BUN levels to be elevated during cyclosporine therapy. These elevations in renal transplant patients do not necessarily indicate rejection, and each patient must be fully evaluated before dosage adjustment is indicated. These increases reflect a reduction in the glomerular filtration rate. Impaired renal function at any time requires close monitoring, and frequent dosage adjustments may be indicated. The frequency and severity of serum creatinine elevations increase with dose and duration of cyclosporine therapy. These elevations are likely to become more pronounced without dose reduction or discontinuation. 

The major route of fluoride excretion is via the kidney and urine 40-60% of the daily intake is excreted in the urine with an elimination half-life of about 5 h [17,85]. Fluoride excretion is influenced by a number of factors, including glomerular filtration rate, urinary flow and urinary pH. The excretion of fluoride in urine is reduced in individuals with impaired renal function. Urine fluoride excretion is 0.79 mg/day in humans with normal renal function, 0.53 mg/day in those with questionable and 0.27 mg/day in those with impaired renal function [86],... 

---